CClinicalTrials.gg
CompletedNCT03470675Updated Apr 24, 2026Results posted

Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries

A Phase 4 interventional study of Epidural saline + IV saline and Epidural morphine 3 mg + IV saline in Pain and Postpartum Depression, sponsored by Northwestern University. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-24.

Sponsored by Northwestern University · Phase 4, Interventional, and Prevention

Phase
Phase 4
Study type
Interventional
Enrollment
67
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Obstetric anal sphincter injuries (OASIS) encompass both third and fourth degree perineal tears. These tears can have a significant impact on women's quality of life in the short and long term. One of the most distressing immediate complications of this severe perineal injury is perineal pain. Women can also experience postpartum depression, dyspareunia, and altered sexual function after OASIS.

This is a randomized controlled trial to study the effects of three interventions (placebo, low dose intravenous ketamine plus epidural morphine, or epidural morphine alone) on acute pain after OASIS.

The objective of this study is to assess the incidence of perineal pain in postpartum patients 1 week after obstetric anal sphincter injuries.

02

Conditions studied

  • Pain
  • Postpartum Depression
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Age >18 years of age
  • English-speaking
  • Vaginal delivery (spontaneous or assisted)
  • A full-term fetus (>37 weeks' gestation)
  • OASIS as assessed by obstetrical provider
  • Functional epidural analgesia at time of delivery
  • Patient amenable to follow-up in specialty perineal clinic within the first week postpartum

Exclusion criteria

Exclusion Criteria:

  • Previous pelvic surgery
  • History of chronic pelvic pain
  • History of recurrent urinary tract infections
  • Women with known malformations of their urinary tract
  • True allergies to ketamine and/or morphine
  • Preeclampsia or hypertensive disorder at the time of delivery
  • Obstructive sleep apnea
04

Study design

Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
67 participants (actual)

Study arms

  • Placebo comparator
    Epidural saline + IV saline

    Sterile saline via the epidural catheter. Sterile saline via intravenous catheter.

    Drug: Epidural saline + IV saline

  • Active comparator
    Epidural morphine 3 mg + IV saline

    3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter.

    Drug: Epidural morphine 3 mg + IV saline

  • Active comparator
    Epidural morphine 3 mg + IV ketamine 0.3 mg/kg

    3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter.

    Drug: Epidural morphine 3 mg + IV ketamine 0.3 mg/kg

Interventions

  • DrugEpidural saline + IV saline

    Sterile saline injection in the epidural catheter and in the intravenous catheter

  • DrugEpidural morphine 3 mg + IV saline

    Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter

  • DrugEpidural morphine 3 mg + IV ketamine 0.3 mg/kg

    Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter

05

What researchers measure

Primary outcomes

  1. Perineal Pain in Postpartum Patients 1 Week After Obstetric Anal Sphincter Injuries.

    Perineal pain 1 week after vaginal delivery measured using the VRS (verbal rating scale). The scale is scored 0 no pain (good)and 10 highest pain (poor).

    Time frame: 1 week after vaginal delivery

Secondary outcomes

  1. Perineal Pain

    Perineal pain day 1 after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

    Time frame: Day 1 after delivery

  2. Perineal Pain

    Perineal pain day 7 after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

    Time frame: 1 week after delivery

  3. Assessment of Maternal-infant Bonding

    Assessment of maternal infant bonding using the Maternal Postnatal Attachment Scale (MPAS) questionnaire. 19 total question survey which is scored 1= low attachment and 5 = high attachment for each question. Total scores 19 low attachment (poor) to 95 high maternal infant attachment (good).

    Time frame: 1 week after delivery

  4. Presence of Postpartum Depression

    Presence of postpartum depression 7 days after delivery determined by using the Edinburgh Postnatal Depression Scale questionnaire. The questionnaire uses 10 questions scored 0 low to 3 high for a total score of 0 low- 30 high. High scores indicate potential for depression.

    Time frame: 1 week after delivery

  5. Brief Pain Inventory (BPI-ST Short Form) Current Pain

    Part 1 of the 7 question survey (Current Pain). 0 no pain -10 worst pain you can imagine scale.

    Time frame: 1 week after delivery

  6. Presence of Postpartum Depression

    Presence of postpartum depression 6 weeks after delivery determined by using the Edinburgh Postnatal Depression Scale questionnaire. The questionnaire uses 10 questions scored 0 low to 3 high for a total score of 0 low 30 high. High scores indicate potential for depression.

    Time frame: 6 weeks after delivery

  7. Perineal Pain

    Perineal pain 6 weeks after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

    Time frame: 6 weeks after delivery

  8. Assessment of Maternal-infant Bonding

    Assessment of maternal infant bonding using the Maternal Postnatal Attachment Scale (MPAS) questionnaire. 19 total question survey which is scored 1= low attachment and 5 = high attachment for each question. Total scores 19 low attachment to 95 high maternal infant attachment.

    Time frame: 6 weeks after delivery

  9. Brief Pain Inventory (BPI-ST Short Form) Current Pain

    Part 1 of the 7 question survey (Current Pain). 0 no pain -10 worst pain you can imagine scale.

    Time frame: 6 weeks after delivery

  10. Perineal Pain

    Perineal pain 3 months after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

    Time frame: 3 months after delivery

  11. Assessment of Maternal-infant Bonding

    Assessment of maternal infant bonding using the Maternal Postnatal Attachment Scale (MPAS) questionnaire. 19 total question survey which is scored 1= low attachment and 5 = high attachment for each question. Total scores 19 low attachment to 95 high maternal infant attachment.

    Time frame: 3 months after delivery

  12. Female Sexual Function

    Female Sexual Function Index questionnaire (FSFI).This is a 19 question survey which is scored 2 low sexual function to 36 high sexual function.

    Time frame: 3 months after delivery

  13. Brief Pain Inventory (BPI-ST Short Form) Current Pain

    Part 1 of the 7 question survey (Current Pain). 0 no pain -10 worst pain you can imagine scale.

    Time frame: 3 months after delivery

  14. Promis 29 Profile (Physical Function Question Only)

    29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher physical function.

    Time frame: 3 month

  15. Promis 29 Profile (Anxiety Function Question Only)

    29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 anxiety rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher anxiety.

    Time frame: 3 month

  16. Promis 29 Profile (Depressive Symptoms Question Only)

    29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher depression.

    Time frame: 3 month

  17. Promis 29 Profile (Fatigue Question Only)

    29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher level of fatigue.

    Time frame: 3 month

  18. Promis 29 Profile (Sleep Disturbance Question Only)

    29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher level of sleep disturbance.

    Time frame: 3 month

  19. Promis 29 Profile (Social Function Question Only)

    29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher level of social function.

    Time frame: 3 month

  20. Promis 29 Profile (Pain Interference Question Only)

    29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates a higher level of pain interference.

    Time frame: 3 month

  21. Perineal Pain

    Perineal pain 1 year after vaginal delivery measured using the VRS (verbal rating scale). The scale is scored 0 no pain (good) and 10 highest pain (poor).

    Time frame: 1 year after delivery

06

Results

Posted Apr 24, 2026
Limitations and caveats
This project enrollment was closed early because of loss of funding.

Participant flow

Participant flow — Overall Study
MilestoneEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Started152626
Completed81721
Not completed795
Withdrew: Lost to follow-up795

Outcome measures

PrimaryPerineal Pain in Postpartum Patients 1 Week After Obstetric Anal Sphincter Injuries.

Perineal pain 1 week after vaginal delivery measured using the VRS (verbal rating scale). The scale is scored 0 no pain (good)and 10 highest pain (poor).

Time frame:
1 week after vaginal delivery
Reported as:
Mean · score on a scale
Perineal Pain in Postpartum Patients 1 Week After Obstetric Anal Sphincter Injuries.
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Perineal Pain in Postpartum Patients 1 Week After Obstetric Anal Sphincter Injuries.3.5 (2.3 to 4.7)2.7 (2.0 to 3.4)2.4 (1.7 to 3.1)
SecondaryPerineal Pain

Perineal pain day 1 after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

Time frame:
Day 1 after delivery
Reported as:
Mean · score on a scale
Perineal Pain
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Perineal Pain14.4 (10.0 to 18.9)10.4 (7.9 to 12.9)12.9 (10.0 to 15.8)
SecondaryPerineal Pain

Perineal pain day 7 after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

Time frame:
1 week after delivery
Reported as:
Mean · score on a scale
Perineal Pain
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Perineal Pain9.5 (6.9 to 12.1)9.4 (6.2 to 12.7)8.9 (6.6 to 11.2)
SecondaryAssessment of Maternal-infant Bonding

Assessment of maternal infant bonding using the Maternal Postnatal Attachment Scale (MPAS) questionnaire. 19 total question survey which is scored 1= low attachment and 5 = high attachment for each question. Total scores 19 low attachment (poor) to 95 high maternal infant attachment (good).

Time frame:
1 week after delivery
Reported as:
Mean · Score on a scale
Assessment of Maternal-infant Bonding
Score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Assessment of Maternal-infant Bonding82.5 (78.4 to 86.7)79.1 (73.9 to 84.2)83.8 (81.8 to 85.9)
SecondaryPresence of Postpartum Depression

Presence of postpartum depression 7 days after delivery determined by using the Edinburgh Postnatal Depression Scale questionnaire. The questionnaire uses 10 questions scored 0 low to 3 high for a total score of 0 low- 30 high. High scores indicate potential for depression.

Time frame:
1 week after delivery
Reported as:
Mean · score on a scale
Presence of Postpartum Depression
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Presence of Postpartum Depression5.7 (2.9 to 8.6)7.0 (4.7 to 9.4)6.7 (4.9 to 9.4)
SecondaryBrief Pain Inventory (BPI-ST Short Form) Current Pain

Part 1 of the 7 question survey (Current Pain). 0 no pain -10 worst pain you can imagine scale.

Time frame:
1 week after delivery
Reported as:
Mean · score on a scale
Brief Pain Inventory (BPI-ST Short Form) Current Pain
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Brief Pain Inventory (BPI-ST Short Form) Current Pain3.0 (2.2 to 3.8)2.3 (1.6 to 3.1)2.2 (1.6 to 2.9)
SecondaryPresence of Postpartum Depression

Presence of postpartum depression 6 weeks after delivery determined by using the Edinburgh Postnatal Depression Scale questionnaire. The questionnaire uses 10 questions scored 0 low to 3 high for a total score of 0 low 30 high. High scores indicate potential for depression.

Time frame:
6 weeks after delivery
Reported as:
Mean · score on a scale
Presence of Postpartum Depression
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Presence of Postpartum Depression5.1 (2.6 to 7.6)4.7 (2.8 to 6.6)4.8 (3.3 to 6.3)
SecondaryPerineal Pain

Perineal pain 6 weeks after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

Time frame:
6 weeks after delivery
Reported as:
Mean · score on a scale
Perineal Pain
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Perineal Pain1.7 (.3 to 3.1)5.2 (1.4 to 9)3.8 (1.9 to 5.7)
SecondaryAssessment of Maternal-infant Bonding

Assessment of maternal infant bonding using the Maternal Postnatal Attachment Scale (MPAS) questionnaire. 19 total question survey which is scored 1= low attachment and 5 = high attachment for each question. Total scores 19 low attachment to 95 high maternal infant attachment.

Time frame:
6 weeks after delivery
Reported as:
Mean · Score on a scale
Assessment of Maternal-infant Bonding
Score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Assessment of Maternal-infant Bonding83.2 (78.8 to 87.6)80.9 (76.8 to 85.1)85.0 (82.4 to 87.7)
SecondaryBrief Pain Inventory (BPI-ST Short Form) Current Pain

Part 1 of the 7 question survey (Current Pain). 0 no pain -10 worst pain you can imagine scale.

Time frame:
6 weeks after delivery
Reported as:
Mean · score on a scale
Brief Pain Inventory (BPI-ST Short Form) Current Pain
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Brief Pain Inventory (BPI-ST Short Form) Current Pain.3 (0 to .6).5 (.1 to 1.0).7 (.1 to 1.3)
SecondaryPerineal Pain

Perineal pain 3 months after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

Time frame:
3 months after delivery
Reported as:
Mean · score on a scale
Perineal Pain
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Perineal Pain.8 (.3 to 2.0)3.2 (.8 to 5.6)1 (.4 to 1.7)
SecondaryAssessment of Maternal-infant Bonding

Assessment of maternal infant bonding using the Maternal Postnatal Attachment Scale (MPAS) questionnaire. 19 total question survey which is scored 1= low attachment and 5 = high attachment for each question. Total scores 19 low attachment to 95 high maternal infant attachment.

Time frame:
3 months after delivery
Reported as:
Mean · Scores on a scale
Assessment of Maternal-infant Bonding
Scores on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Assessment of Maternal-infant Bonding4.0 (2.3 to 5.8)3.6 (2.0 to 5.3)4.4 (3.1 to 5.7)
SecondaryFemale Sexual Function

Female Sexual Function Index questionnaire (FSFI).This is a 19 question survey which is scored 2 low sexual function to 36 high sexual function.

Time frame:
3 months after delivery
Reported as:
Mean · Score on scale 2 low 36 high
Female Sexual Function
Score on scale 2 low 36 highEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Female Sexual Function13 (8.4 to 17.6)14.2 (10.2 to 18.2)14.8 (11.1 to 18.5)
SecondaryBrief Pain Inventory (BPI-ST Short Form) Current Pain

Part 1 of the 7 question survey (Current Pain). 0 no pain -10 worst pain you can imagine scale.

Time frame:
3 months after delivery
Reported as:
Mean · score on a scale
Brief Pain Inventory (BPI-ST Short Form) Current Pain
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Brief Pain Inventory (BPI-ST Short Form) Current Pain.2 (.2 to .7).6 (0.0 to 1.1)0.0 (0.0 to 0.2)
SecondaryPromis 29 Profile (Physical Function Question Only)

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher physical function.

Time frame:
3 month
Reported as:
Mean · T score
Promis 29 Profile (Physical Function Question Only)
T scoreEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Promis 29 Profile (Physical Function Question Only)52.9 (48.4 to 57.5)54.8 (52.7 to 56.8)54.8 (52.9 to 56.6)
SecondaryPromis 29 Profile (Anxiety Function Question Only)

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 anxiety rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher anxiety.

Time frame:
3 month
Reported as:
Mean · T score
Promis 29 Profile (Anxiety Function Question Only)
T scoreEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Promis 29 Profile (Anxiety Function Question Only)44.8 (39.3 to 50.3)45.3 (43.0 to 53.6)46.7 (43.9 to 49.6)
SecondaryPromis 29 Profile (Depressive Symptoms Question Only)

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher depression.

Time frame:
3 month
Reported as:
Mean · T score
Promis 29 Profile (Depressive Symptoms Question Only)
T scoreEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Promis 29 Profile (Depressive Symptoms Question Only)45 (42.1 to 48.0)43 (40.9 to 45.2)43.6 (41.2 to 45.9)
SecondaryPromis 29 Profile (Fatigue Question Only)

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher level of fatigue.

Time frame:
3 month
Reported as:
Mean · T score
Promis 29 Profile (Fatigue Question Only)
T scoreEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Promis 29 Profile (Fatigue Question Only)45.9 (41.6 to 50.3)48.1 (44.1 to 52.1)50.0 (47.9 to 53.2)
SecondaryPromis 29 Profile (Sleep Disturbance Question Only)

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher level of sleep disturbance.

Time frame:
3 month
Reported as:
Mean · T score
Promis 29 Profile (Sleep Disturbance Question Only)
T scoreEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Promis 29 Profile (Sleep Disturbance Question Only)58.3 (55.6 to 61.0)56.0 (54.0 to 57.9)54.8 (51.1 to 58.6)
SecondaryPromis 29 Profile (Social Function Question Only)

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher level of social function.

Time frame:
3 month
Reported as:
Mean · T score
Promis 29 Profile (Social Function Question Only)
T scoreEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Promis 29 Profile (Social Function Question Only)55.8 (50.7 to 61.0)53.8 (50.3 to 57.3)55.3 (52.4 to 58.2)
SecondaryPromis 29 Profile (Pain Interference Question Only)

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates a higher level of pain interference.

Time frame:
3 month
Reported as:
Mean · T score
Promis 29 Profile (Pain Interference Question Only)
T scoreEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Promis 29 Profile (Pain Interference Question Only)44 (40.6 to 47.5)43 (41.4 to 44.4)43.5 (41.7 to 45.2)
SecondaryPerineal Pain

Perineal pain 1 year after vaginal delivery measured using the VRS (verbal rating scale). The scale is scored 0 no pain (good) and 10 highest pain (poor).

Time frame:
1 year after delivery
Reported as:
Mean · score on a scale
Perineal Pain
score on a scaleEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Perineal Pain.1 (.1 to .2).5 (.1 to 1.1).3 (.1 to .5)

Adverse events

Collected over 48 Hours after delivery of baby.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Epidural Saline + IV Saline0/14 (0%)0/14 (0%)4/14 (28.6%)
Epidural Morphine 3 mg + IV Saline0/26 (0%)0/26 (0%)14/26 (53.8%)
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg0/25 (0%)0/25 (0%)13/25 (52%)
Most frequent other events
Most frequent other events
EventEpidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
Back AcheMusculoskeletal and connective tissue disorders1/146/264/25
HypotensionCardiac disorders2/143/262/25
NauseaGastrointestinal disorders0/142/263/25
PruritusGeneral disorders0/143/262/25
VomitingGastrointestinal disorders0/141/262/25
FeverGeneral disorders0/142/261/25
Wound ProblemsGeneral disorders1/140/260/25
HivesGeneral disorders0/141/260/25

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Epidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kgTotal
Mean34.7 (31.3 to 38.1)31.2 (27.3 to 35.1)33.9 (30.5 to 37.4)33 (27.3 to 38.1)
Sex: Female, Male
Sex: Female, Male(Participants)Epidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kgTotal
Female14262565
Male0000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Epidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kgTotal
American Indian or Alaska Native0000
Asian0000
Native Hawaiian or Other Pacific Islander0000
Black or African American65516
White8181844
More than one race0000
Unknown or Not Reported0325
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Epidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kgTotal
Hispanic LatinX0112
Not LatinX14252463
Region of Enrollment
Region of Enrollment(participants)Epidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kgTotal
United States14262565
Current Smoker
Current Smoker(Participants)Epidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kgTotal
Count of participants1001
Gravida
Gravida(number of participants)Epidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kgTotal
1 Time10171441
2 Times16915
Greater than 2 times3328
Para
Para(number of participants)Epidural Saline + IV SalineEpidural Morphine 3 mg + IV SalineEpidural Morphine 3 mg + IV Ketamine 0.3 mg/kgTotal
No births25310
1 birth11171644
2 births14611

17 further baseline measures are reported on the registry.

07

Study locations

1 site
  • Northwestern University
    Chicago, Illinois 60611, United States
08

References and documents

Publications

  • Harvey MA, Pierce M, Alter JE, Chou Q, Diamond P, Epp A, Geoffrion R, Harvey MA, Larochelle A, Maslow K, Neustaedter G, Pascali D, Pierce M, Schulz J, Wilkie D, Sultan A, Thakar R; Society of Obstetricians and Gynaecologists of Canada. Obstetrical Anal Sphincter Injuries (OASIS): Prevention, Recognition, and Repair. J Obstet Gynaecol Can. 2015 Dec;37(12):1131-48. doi: 10.1016/s1701-2163(16)30081-0. PubMed 26637088 ↗
  • Macarthur AJ, Macarthur C. Incidence, severity, and determinants of perineal pain after vaginal delivery: a prospective cohort study. Am J Obstet Gynecol. 2004 Oct;191(4):1199-204. doi: 10.1016/j.ajog.2004.02.064. PubMed 15507941 ↗
  • Chang SR, Chen KH, Lee CN, Shyu MK, Lin MI, Lin WA. Relationships between perineal pain and postpartum depressive symptoms: A prospective cohort study. Int J Nurs Stud. 2016 Jul;59:68-78. doi: 10.1016/j.ijnurstu.2016.02.012. Epub 2016 Feb 26. PubMed 27222452 ↗
  • Bauchat JR, Higgins N, Wojciechowski KG, McCarthy RJ, Toledo P, Wong CA. Low-dose ketamine with multimodal postcesarean delivery analgesia: a randomized controlled trial. Int J Obstet Anesth. 2011 Jan;20(1):3-9. doi: 10.1016/j.ijoa.2010.10.002. PubMed 21224020 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 23, 2019
  • Informed consent form · Aug 30, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03470675
Lead sponsor
Northwestern University
Responsible party
Feyce M. Peralta, MD, MS (Principal Investigator, Northwestern University) — Principal investigator
First posted
Mar 20, 2018
Start date
Jun 27, 2018
Primary completion
May 20, 2024
Completion
Jun 20, 2024
Results posted
Apr 24, 2026
Last update
Apr 24, 2026

Study contacts

Feyce Peralta, MD
principal investigator · Northwestern University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion